Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Long-Term Investments (2019 - 2021)

Updated

Analysis

Aligos Therapeutics (ALGS) Long-Term Investments (2019 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 387.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - 63.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 1.45 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 15.11 Mn
Sep 30, 2021 492,000.00
Sep 30, 2020 15.01 Mn
Dec 31, 2019 10.02 Mn
API Access

Aligos Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ALGS&period=max&api_key=YOUR_API_KEY